Next 10 |
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May...
2023-04-12 12:55:56 ET Gainers: National CineMedia ( NCMI ) +151% . TESSCO Technologies Incorporated ( TESS ) +87% . Guardforce AI ( GFAI ) +51% . Bullfrog AI Holdings ( BFRG ) +32% . Altamira Therapeutics ( CYTO ) +28% . Tri...
Chronic conditions include diabetes, hypertension, anxiety, depression, low back pain, and prenatal care Babylon’s technology will collect and analyze data to monitor patients in real-time Personalized care teams will tailor evidence-based programs for each member C...
2023-03-09 11:20:53 ET The following slide deck was published by Babylon Holdings Limited in conjunction with their 2022 Q4 earnings call. For further details see: Babylon Holdings Limited 2022 Q4 - Results - Earnings Call Presentation
2023-03-09 11:19:13 ET Babylon Holdings Limited (BBLN) Q4 2022 Earnings Conference Call March 09, 2023, 08:00 AM ET Company Participants Ali Parsa - Founder and Chief Executive Officer David Humphreys - Chief Financial Officer Saurabh Johri - Chief Scientific Off...
2023-03-09 06:06:53 ET Babylon Holdings press release ( NYSE: BBLN ): Q4 GAAP EPS of -$4.50 misses by $0.08 . Revenue of $289M (+145.7% Y/Y) misses by $1.4M . Outlook: Babylon has successfully implemented nearly $125 million in annualized cost reductions, w...
Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable 1 , with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins 2 in t...
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference ca...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today confirmed that its revenue for the year ended December 31, 2022 is expected to exceed $1.05 billion on both a U.S. GAAP and International Financial Reporting Standards (IFRS) basis, including reve...
Summary Today, we put digital healthcare concern Babylon Holdings Limited in the spotlight for the first time. Despite impressive revenue growth, the shares of this small cap company have been pummeled in the markets. Can Babylon Holdings Limited stock stage a turnaround in 2023?...
News, Short Squeeze, Breakout and More Instantly...
Babylon Holdings Limited Class A Company Name:
BBLN Stock Symbol:
NYSE Market:
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May...
Chronic conditions include diabetes, hypertension, anxiety, depression, low back pain, and prenatal care Babylon’s technology will collect and analyze data to monitor patients in real-time Personalized care teams will tailor evidence-based programs for each member C...
Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable 1 , with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins 2 in t...